Bibliography of the person, including all types of documents, not only theses.

MSc theses (3)

1. Romana Vidergar: Študija vloge katepsina L pri apoptozi glioblastomskih celic z uporabo sinteznih ireverzibilnih inhibitorjev katepsina L
2. Petra Erjavec: Optimizacija gojenja mezenhimskih matičnih celic iz maščevja na mikronosilcih v mešalnem biorekatorju
3. Teja Rajar: Razvoj metode za določitev dovzetnosti mezenhimskih matičnih celic na sproženo senescenco

BSc theses (3)

1. Katarina Maher: Toksičnost ksantohumola za različne vrste normalnih in rakavih celic
2. Barbara Jerič Kokelj: Vsebnost cisteinskih proteaz kot pokazatelj invazivnosti v humanih mezenhimskih matičnih celicah v primerjavi z glioblastomskimi celičnimi linijami U87-MG, U373 in U251
3. Irina Nemet: Opredelitev lastnosti mezenhimskih matičnih celic in njihovega vpliva na izolacijo celic CD133+ iz primarne kulture glioblastoma

Other documents (26)

1. Bernarda Majc, Anamarija Habič, Metka Novak, Ana Rotter, Andrej Porčnik, Jernej Mlakar, Vera Župunski, Urša Pečar Fonović, Damijan Knez, Nace Zidar, Stanislav Gobec, Janko Kos, Tamara Lah Turnšek, Anja Pišlar, Barbara Breznik: Upregulation of cathepsin X in glioblastoma
2. Tamara Lah Turnšek: Tumor progression and invasion
3. Anja Bubik, Robert Frangež, Monika C. Žužek, Ion Gutiérrez-Aguirre, Tamara Lah Turnšek, Bojan Sedmak: Cyanobacterial cyclic peptides can disrupt cytoskeleton organization in human astrocytes
4. Bojana Žegura, Irena Zajc, Tamara Lah Turnšek, Metka Filipič: Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis
5. Javor Kac, Janja Plazar, Aleš Mlinarič, Bojana Žegura, Tamara Lah Turnšek, Metka Filipič: Antimutagenicity of hops (Humulus lupulus L.): bioassay-directed fractionationand isolation of xanthohumol
6. Bojana Žegura, Meta Volčič, Tamara Lah Turnšek, Metka Filipič: Different sensitivities of human colon adenocarcinoma (CaCo-2), astrocytoma (IPDDC-A2) and lymphoblastoid (NCNC) cell lines to microcystin-LR induced reactive oxygen species and DNA damage
7. Boris Gole, María Beatriz Durán-Alonso, Vinko V. Dolenc, Tamara Lah Turnšek: Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro
8. Helena Motaln, Christian Schichor, Tamara Lah Turnšek: Human mesenchymal stem cells and their use in cell-based therapies
9. Anja Pucer, Bojana Mirković, Ingrid Falnoga, Zdenka Šlejkovec, Ciro Isidoro, Tamara Lah Turnšek: Differential role of cathepsins B and L in autophagy-associated cell death induced by arsenic trioxide in U87 human glioblastoma cells
10. Anja Torsvik, Monika Primon, Tamara Lah Turnšek, Helena Motaln: Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination
11. Roberta Castino, Anja Pucer, Roberta Veneroni, Federica Morani, Claudia Peracchio, Tamara Lah Turnšek, Ciro Isidoro: Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells
12. Helena Motaln, Kristina Gruden, Matjaž Hren, Christian Schichor, Monika Primon, Ana Rotter, Tamara Lah Turnšek: Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma
13. Irena Zajc, Metka Filipič, Tamara Lah Turnšek: Xanthohumol induces different cytotoxicity and apoptotic pathways in malignant and normal astrocytes
14. Mateja Robič, Helena Motaln, Urška Verbovšek, Tamara Lah Turnšek: Vloga matičnih celic pri napredovanju in zdravljenju glioma
15. Metka Novak, Miha Koprivnikar Krajnc, Barbara Hrastar, Barbara Breznik, Bernarda Majc, Mateja Mlinar, Ana Rotter, Andrej Porčnik, Jernej Mlakar, Katja Stare, Richard G. Pestell, Tamara Lah Turnšek: CCR5-mediated signaling is involved in invasion of glioblastoma cells in its microenvironment
16. Saša Kenig, María Beatriz Durán-Alonso, Margareta M. Mueller, Tamara Lah Turnšek: Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9
17. Seyed Yousef Ardebili, Irena Zajc, Boris Gole, Benito Campos, Christel Herold-Mende, Sara Drmota Prebil, Tamara Lah Turnšek: CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsine' expression in gliobastoma derived spheroids
18. Andrej Porčnik, Metka Novak, Barbara Breznik, Bernarda Majc, Barbara Hrastar, Neja Šamec, Alja Zottel, Ivana Jovchevska, Miloš Vittori, Ana Rotter, Radovan Komel, Tamara Lah Turnšek: TRIM28 selective nanobody reduces glioblastoma stem cell invasion
19. Bojan Sedmak, Tina Eleršek, Olga Grach-Pogrebinsky, Shmuel Carmeli, Nataša Sever, Tamara Lah Turnšek: Ecotoxicologically relevant cyclic peptides from cyanobacterial bloom (Planktothrix rubecens) - a threat to human and environmental health
20. Irena Zajc, Aleš Bervar, Tamara Lah Turnšek: Cysteine cathepsins, stefins and extracellular matrix degradation during invasion of transformed human breast cell lines
21. Irena Zajc, Leonida Frangež, Tamara Lah Turnšek: Expression of cathepsin B is related to tumorigenicity of breast cancer cell lines
22. Miha Trinkaus, Andrej Vranič, Vinko V. Dolenc, Tamara Lah Turnšek: Cathepsin L in human meningiomas
23. Bojana Žegura, Metka Filipič, Dušan Šuput, Tamara Lah Turnšek, Bojan Sedmak: In vitro genotoxicity of microcystin-RR on primary cultured rat hepatocites and Hep G2 cell line detected by Comet assay
24. Nataša Sever, Nataša Levičar, Irena Zajc, Aleš Bervar, Tamara Lah Turnšek: In vitro invasion of transfected human breast epithelial cells MCF10A-neoT
25. Alja Zottel, Metka Novak, Neja Šamec, Bernarda Majc, Sara Colja, Mojca Katrašnik, Miloš Vittori, Barbara Hrastar, Ana Rotter, Andrej Porčnik, Tamara Lah Turnšek, Radovan Komel, Barbara Breznik, Ivana Jovchevska: Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivo
26. Luka Dobovišek, Metka Novak, Fran Krstanović, Simona Borštnar, Tamara Lah Turnšek, Nataša Debeljak: Effect of combining CBD with standard breast cancer therapeutics